A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

NCT03192176 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause
Hot Flashes

Interventions

DRUG: Fezolinetant
DRUG: Placebo

Sponsor

Astellas Pharma Global Development, Inc.